Graft-vs-host disease after small bowel transplantation in children

Journal of Pediatric Surgery

Volumn 45, Issue 2, 2010, Pages 330-336

  Andres, Ane M ^a   Santamaría, Manuel Lopez ^a   Ramos, Esther ^a   Sarriá, Jesus ^a   Molina, Manuel ^a   Hernandez, Francisco ^a   Encinas, Jose L ^a   Larrauri, Javier ^a   Prieto, Gerardo ^a   Tovar, Juan Antonio ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Graft vs host disease; Small bowel transplantation

Indexed keywords

BASILIXIMAB; INFLIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; ARTICLE; CHILD; CHIMERA; CLINICAL ARTICLE; COLONOSCOPY; CONJUNCTIVITIS; DIARRHEA; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; GLOMERULONEPHRITIS; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE GRAFT; INTESTINE TRANSPLANTATION; KIDNEY FAILURE; LIVER GRAFT; MALE; OPHTHALMOSCOPY; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SKIN BIOPSY; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; CHIMERISM; COMBINED MODALITY THERAPY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INFANT; INTESTINE, SMALL; MALE; POSTOPERATIVE COMPLICATIONS; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 75749096798     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2009.10.071     Document Type: Article

References (33)

1. Willenbacher W., Basara N., Blau I.W., et al. Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab. Br J Haematol 112 (2001) 820-823
2. Mazariegos G.V., Abu-Elmagd K., Jaffe R., et al. Graft versus host disease in intestinal transplantation. Am J Transplant 4 (2004) 1459-1465
3. Davison J., Darbyshire P., Beath S.V., et al. Refractory graft versus host disease after pediatric intestinal transplantation-beware of pre-existing immunodeficiency. Transplantation 86 (2008) 179
4. Kato T., Tzakis A.G., Selvaggi G., et al. Intestinal and multivisceral transplantation in children. Ann Surg 243 (2006) 756-764 discussion 64-6
5. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15 (1995) 825-828
6. Fryer J.P. Intestinal transplantation: current status. Gastroenterol Clin North Am 36 (2007) 145-159 vii
7. Abu-Elmagd K.M., Costa G., Bond G.J., et al. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int 22 (2009) 96-109
8. Abu-Elmagd K., Reyes J., Bond G., et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg 234 (2001) 404-416 [discussion 16-7]
9. Loffeler S., Meyer D., Otto C., et al. Different kinetics of donor cell populations after isolated liver and combined liver/small bowel transplantation. Transpl Int 13 Suppl 1 (2000) S537-S540
10. Reyes J., Mazariegos G.V., Abu-Elmagd K., et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant 5 (2005) 1430-1436
11. Vianna R.M., Mangus R.S., Fridell J.A., et al. Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation. Transplantation 85 (2008) 1290-1293
12. Starzl T.E., Demetris A.J., Murase N., et al. Cell migration, chimerism, and graft acceptance. Lancet 339 (1992) 1579-1582
13. Martin P.J., McDonald G.B., Sanders J.E., et al. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 10 (2004) 320-327
14. Van Lint M.T., Uderzo C., Locasciulli A., et al. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Blood 92 (1998) 2288-2293
15. Arai S., Margolis J., Zahurak M., et al. Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment. Biol Blood Marrow Transplant 8 (2002) 155-160
16. Reyes J., Mazariegos G.V., Bond G.M., et al. Pediatric intestinal transplantation: historical notes, principles and controversies. Pediatr Transplant 6 (2002) 193-207
17. Pintar T., Pleskovic A., Alessiani M., et al. Skin biopsies predict acute graft-versus-host disease after small bowel transplantation in pigs. Acta Vet Hung 55 (2007) 533-541
18. Pintar T., Zorc-Pleskovic R., Alessiani M., et al. Prognostic value of skin histology in GVHD after intestinal transplantation. Eur J Pediatr Surg 17 (2007) 412-415
19. Langnas A., Chinnakotla S., Sudan D., et al. Intestinal transplantation at the University of Nebraska Medical Center: 1990 to 2001. Transplant Proc 34 (2002) 958-960
20. Bruner R.J., and Farag S.S. Monoclonal antibodies for the prevention and treatment of graft-versus-host disease. Semin Oncol 30 (2003) 509-519
21. Remberger M., Aschan J., Barkholt L., et al. Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin. Clin Transplant 15 (2001) 147-153
22. Dugan M.J., DeFor T.E., Steinbuch M., et al. ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival. Ann Hematol 75 (1997) 41-46
23. Bolanos-Meade J., Jacobsohn D.A., Margolis J., et al. Pentostatin in steroid-refractory acute graft-versus-host disease. J Clin Oncol 23 (2005) 2661-2668
24. Khoury H., Kashyap A., Adkins D.R., et al. Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin. Bone Marrow Transplant 27 (2001) 1059-1064
25. Benito A.I., Furlong T., Martin P.J., et al. Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease. Transplantation 72 (2001) 1924-1929
26. Shapira M.Y., Resnick I.B., Dray L., et al. A new induction protocol for the control of steroid refractory/dependent acute graft versus host disease with alefacept and tacrolimus. Cytotherapy 11 (2009) 61-67
27. Patriarca F., Sperotto A., Damiani D., et al. Infliximab treatment for steroid-refractory acute graft-versus-host disease. Haematologica 89 (2004) 1352-1359
28. Couriel D.R., Hicks K., Giralt S., et al. Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation. Curr Opin Oncol 12 (2000) 582-587
29. Przepiorka D., Kernan N.A., Ippoliti C., et al. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood 95 (2000) 83-89
30. Hubbard V.M., Eng J.M., Ramirez-Montagut T., et al. Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation. Blood 106 (2005) 3285-3292
31. + regulatory T cells are numerically deficient in acute and chronic GvHD. Blood 107 (2006) 1717-1723
32. Song J., Ito T., Matsuda C., et al. Regulation of donor T cells in the tolerant rats to graft-versus-host disease by FTY720 following small bowel transplantation. Transplant Proc 38 (2006) 3181-3183
33. Song J., Ito T., Matsuda C., et al. Inhibition of donor-derived T cells trafficking into target organs by FTY720 during acute graft-versus-host disease in small bowel transplantation. Clin Exp Immunol 146 (2006) 85-92